| Typicality: | 0.375 |
| Saliency: | 0.294 |
| for females ages 9 to 26 | 2 | transitive-object |
| vaccine → be licensed in → 2006 | 14 |
| vaccine → be approved in → 2006 | 12 |
| negative | neutral | positive |
| 0.118 | 0.662 | 0.220 |
| Raw frequency | 26 |
| Normalized frequency | 0.294 |
| Modifier score | 0.500 |
| Perplexity | 48.830 |